• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Putative nuclease HARBI1 (HARBI1)

ACP12585

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP12585 Target NameHARBI1
Target SynonymsHARBI1; C11orf77; Putative nuclease HARBI1; EC 3.1.-.-; Harbinger transposase-derived nucleaseFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-349
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ96MB7
Background Information
  • Uniprot Id

    Q96MB7

  • Target Species

    Human

  • Target Name

    HARBI1

  • Target Full Name

    Putative nuclease HARBI1

  • Target Function

    Transposase-derived protein that may have nuclease activity (Potential). Does not have transposase activity.

  • Target Subcellular Location

    Nucleus. Cytoplasm. Note=Interaction with NAIF1 promotes translocation to the nucleus.

  • Target Protein Families

    HARBI1 family

  • Target Tissue Specificity

    Detected in brain, eye, nerve tissue, kidney and lung.

  • Target Synonyms

    HARBI1; C11orf77; Putative nuclease HARBI1; EC 3.1.-.-; Harbinger transposase-derived nuclease

  • Target Background

    Predicted to enable metal ion binding activity and nuclease activity. Predicted to be involved in nucleic acid phosphodiester bond hydrolysis. Located in centriolar satellite; cytosol; and plasma membrane.

Inquire Recombinant Human Putative nuclease HARBI1 (HARBI1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification